Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells

Cancer Research

Volumn 60, Issue 22, 2000, Pages 6537-6543

  Sun, S Y ^a   Yue, P ^a   Waun Ki Hong, ^a   Lotan, R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CELL SURFACE RECEPTOR; DACTINOMYCIN; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; MUTANT PROTEIN; PROTEIN P53; RETINOID; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; FAS LIGAND PROTEIN; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; NUCLEAR PROTEINS; RECEPTORS, RETINOIC ACID; RETINOIDS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0033707095     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. The Fas death factor
2. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor supeffamily, in normal and neoplastic cells
3. Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
4. The role of APO-1-mediated apoptosis in the immune system
5. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice
6. Fas and Fas ligand interactions suppress melanoma lung metastasis
7. Monoclonal antibody-mediated tumor regression by induction of apoptosis
8. Fas ligand: A sensor for DNA damage critical in skin cancer etiology
9. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
10. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
11. Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells
12. Up-regulation of Fas (CD95) in human p53 wild-type cancer cells treated with ionizing radiation
13. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment
14. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
15. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
16. p53 in signaling checkpoint arrest and apoptosis
17. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
18. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
19. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells
20. p53 modulation of Fas/Apo- 1 mediated apoptosis in a human renal cell carcinoma cell line
21. Role of p53 tumor suppressor gene and Fas/Apo-1 in induction of apoptosis and differentiation of cancer cells
22. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: Relationship between responsiveness to anti-Fas mAb and p53 functional status
23. p53-dependent, DNA damage-induced apoptosis requires Fas/APO-independent activation of CPP32β
24. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
25. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells
26. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro and causes growth inhibition in xenografts in vivo
27. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 613-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437)
28. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway
29. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells
30. Molecular determination of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines
31. Induction of apoptosis in human non-small cell lung carcinoma cells by a novel synthetic retinoid CD437
32. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ
33. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells
34. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells
35. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells
36. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ms mutations and clinical features
37. p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines
38. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
39. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
40. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids
41. A decade of molecular biology of retinoic acid receptors
42. Post-transcriptional regulation of MyD118 and GADD45 in human lung carcinoma cells during 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2- naphthalene carboxylic acid-induced apoptosis
43. Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance
44. Human lung carcinomas express Fas ligand